Contextlogic Holdings Inc 's

• LOGC's Stock Performance relative to its Competitors

Taysha Gene Therapies Inc Share Performance -11.67% 30 Days

Taysha Gene Therapies Inc Profile Taysha Gene Therapies Inc operates under a business model focused on developing and commercializing innovative genetic therapies to treat and potentially cure patients with rare monogenic diseases. Utilizing cutting-edge technologies, the company aims to bring transformative treatments to market in order to improve the lives of individuals suffering from these rare genetic disorders. More about Taysha Gene Therapies Inc 's Market Share

Editas Medicine Inc Share Performance +11.38% 30 Days

Editas Medicine Inc Profile Editas Medicine Inc.'s business model revolves around developing and commercializing transformative genome editing technologies to treat serious diseases. More about Editas Medicine Inc 's Market Share

Crispr Therapeutics Ag Share Performance +8.04% 30 Days

Crispr Therapeutics Ag Profile CRISPR Therapeutics AG is a biopharmaceutical company focused on developing transformative gene-based medicines using its CRISPR/Cas9 gene-editing platform. They aim to leverage the potential of CRISPR to treat severe genetic diseases by directly modifying genes within the body's cells. The company collaborates with partners, conducts research and development of their therapeutics, and ultimately aims to bring their innovative treatments to market. More about Crispr Therapeutics Ag's Market Share

Cargo Therapeutics Inc Share Performance -70.30% This Year

Cargo Therapeutics Inc Profile Cargo Therapeutics Inc is a biotechnology company that utilizes a unique business model focused on developing targeted therapeutics. Their approach involves engineering cell-penetrating peptides to deliver various cargoes, such as gene therapies or small molecules, directly to specific cells or tissues, increasing precision and effectiveness of treatments. By leveraging this technology, the company aims to address unmet medical needs with potentially transformative therapies. More about Cargo Therapeutics Inc 's Market Share

Sources: Contextlogic Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 5, 2026 3:13 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Contextlogic Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.